GC CORP. purchased 816.4% of their position (1.43M shares) of ARTIVA BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $16.50M — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/28/2026ACC: 0001931382-26-000007
+1.43M
Net shares
Net buyer
$16.50M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.43M acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.09M
Price / share
$11.52
Trade value
$12.50M
% of position
32.8%
5/11/2026
3.31M→4.39M
Common Stock
Indirect
Shares
+347.22K
Price / share
$11.52
Trade value
$4M
% of position
27.5%
5/11/2026
1.26M→1.61M
Total
Net shares
+1.43M
Net value
$16.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | P · Purchase | +1.09M | $11.52 | $12.50M | 32.8% | 3.31M | 4.39M |
| Common Stock Indirect | 5/11/2026 | P · Purchase | +347.22K | $11.52 | $4M | 27.5% | 1.26M | 1.61M |
| Total | +1.43M | $16.50M | ||||||
Derivative Transactions0
No derivative transactions reported